FDA Approved: INLEXZO — Original Application (Janssen Biotech, Inc)

View source ↗

Summary

FDA approved INLEXZO, gemcitabine delivered intravesically, under Janssen’s original NDA for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• INLEXZO (Gemcitabine intravesical)

Snippet

ORIG AP for INLEXZO (GEMCITABINE INTRAVESICAL)